These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16849620)

  • 1. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Cassin M; Meneguzzo N; Viel E; Lestuzzi C; Di Gennaro G; Nicolosi GL
    Ital Heart J Suppl; 2004 Sep; 5(9):735-40. PubMed ID: 15568612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole-induced torsade de pointes.
    Tholakanahalli VN; Potti A; Hanley JF; Merliss AD
    Ann Pharmacother; 2001 Apr; 35(4):432-4. PubMed ID: 11302406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    Elbey MA; Cil H; Onturk E; Islamoglu Y
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
    Vieweg WV; Schneider RK; Wood MA
    Acta Psychiatr Scand; 2005 Oct; 112(4):318-22; author reply 322. PubMed ID: 16156840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulpiride induced torsade de pointes.
    Huang BH; Hsia CP; Chen CY
    Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports.
    Justo D; Zeltser D
    Mycoses; 2006 Nov; 49(6):463-70. PubMed ID: 17022762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.
    Tatetsu H; Asou N; Nakamura M; Hanaoka N; Matsuno F; Horikawa K; Mitsuya H
    Am J Hematol; 2006 May; 81(5):366-9. PubMed ID: 16628725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
    Mok NS; Lo YK; Tsui PT; Lam CW
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
    Glassman AH; Bigger JT
    Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
    Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
    Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT interval prolongation and torsade de pointes.
    Patanè S; Marte F; Di Bella G
    Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT syndrome and torsade de pointes in a patient receiving fluconazole.
    Wassmann S; Nickenig G; Böhm M
    Ann Intern Med; 1999 Nov; 131(10):797. PubMed ID: 10577320
    [No Abstract]   [Full Text] [Related]  

  • 19. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
    Zeltser D; Justo D; Halkin A; Prokhorov V; Heller K; Viskin S
    Medicine (Baltimore); 2003 Jul; 82(4):282-90. PubMed ID: 12861106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced long QT syndrome and torsade de pointes.
    Morissette P; Hreiche R; Turgeon J
    Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.